Microbiotica Overview
- Founded
- 2016
- Status
- Private
- Employees
- 52
- Latest Deal Type
- Series B
- Latest Deal Amount
- $67.4M
- Investors
- 6
Microbiotica General Information
Description
Operator of a biotechnology platform intended to discover and develop live bacterial therapeutics and biomarkers. The company's platform focuses in microbiome science to identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to identify phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.
Contact Information
Website
www.microbiotica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Chesterford Research Park
- Little Chesterford
- Cambridge CB10 1XL
- England, United Kingdom
Microbiotica Timeline
Microbiotica Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 07-Mar-2022 | $67.4M | 000.00 | Completed | Generating Revenue | |
| 3. Later Stage VC | 24-Oct-2018 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Later Stage VC | 21-Dec-2017 | $6.69M | $16.7M | 000.00 | Completed | Generating Revenue |
| 1. Seed Round | 15-Dec-2016 | $10M | $10M | 0000 | Completed | Generating Revenue |
Microbiotica Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 | |
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 30,500 | $0.000131 | $1.31 | $1.31 | 1x | $1.31 | 0.21% |
Microbiotica Patents
Microbiotica Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210275602-A1 | Therapeutic bacterial composition | Pending | 19-May-2020 | 000000000 | |
| US-20210341458-A1 | Bacterial biomarker | Pending | 19-May-2020 | 00000000000 | |
| JP-5665196-B2 | Prevention and treatment of obesity and metabolic diseases caused by obesity using microorganisms | Active | 10-Mar-2009 | 000000000 | |
| US-8986675-B2 | Compositions and methods for prevention and treatment of obesity and obesity related metabolic syndrome | Active | 10-Mar-2009 | 000000000 | 0 |
| US-20120121753-A1 | Compositions and methods for prevention and treatment of obesity and obesity related metabolic syndrome | Granted | 10-Mar-2009 | A61K35/74 | 0 |
Microbiotica Executive Team (8)
Microbiotica Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hans Schikan | Self | Non-Executive Chairman & Board Member | 000 0000 |
| Iain Wilcock | Self | Board Member | 000 0000 |
| John Shields Ph.D | Self | Board Member | 000 0000 |
| Michael Romanos Ph.D | Microbiotica | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Robert Tansley MD | Microbiotica | Board Member | 000 0000 |
Microbiotica Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMicrobiotica Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| British Patient Capital | Fund of Funds | Minority | 000 0000 | 000000 0 | |
| Flerie Invest | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Tencent | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Seventure Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Cambridge Innovation Capital | Venture Capital | Minority | 000 0000 | 000000 0 |